Frank Torti - Apr 2, 2024 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Frank Torti
Stock symbol: IMVT
Transactions as of: Apr 2, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/4/2024, 04:44 PM
Previous filing: May 26, 2023
Next filing: May 24, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+120K	+23.37%	$0.00	636K	Apr 2, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+50.2K		$0.00	50.2K	Apr 2, 2024	Common Stock	50.2K	$30.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
F2	The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.

Content

These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.

The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.